ANI Pharmaceuticals, Inc.

ANIPNASDAQHealthcare● Active

$80.52

$-0.60(-0.73%)

Market Cap$1.8B

P/E Ratio—

52W High$99.5

52W Low$59.61

Avg Volume360K

Open$81.10

Beta0.44

Net Income Financials Revenue

ANI Pharmaceuticals, Inc. (ANIP) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

ANIP · net income · updated Jun 8, 2026

Core profitability metrics

ANIP · net income · margin · TTM · CAGR

Net income was $78.3M for FY2025 (fiscal year ending 2025-12-31), up 522.9% year-over-year. Net profit margin was 8.9%. Based on available data, ANI Pharmaceuticals, Inc. has been profitable since at least 2013.

FY2025 Net Income$78.3M▲ +522.9% YoY

Trailing 12M (TTM)$89.7Mtrailing 4 quarters sum

Net Profit Margin8.9%$78.3M ÷ $883.4M

YoY Change+522.9%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2013

▸ FMP /income-statement · Annual · ANIP net income history · ANIP profit margin

Annual net income data

ANIP · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025$78.3M▲ +522.9%8.9%$883.4M

FY2024Loss−$18.5M▼ 198.6%-3.0%$614.4M

FY2023$18.8M▲ +139.2%3.9%$486.8M

FY2022Loss−$47.9M▼ 12.4%-15.1%$316.4M

FY2021Loss−$42.6M▼ 88.9%-19.7%$216.1M

Net income vs peers (Healthcare)

ANIP vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

ANI Pharmaceuticals, Inc.YOU

ANIP

$78.3M+522.9%8.9%

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

ANI Pharmaceuticals, Inc. (ANIP) reported net income of $78.3M for FY2025 (fiscal year ending 2025-12-31), up 522.9% year-over-year. The net profit margin was 8.9% — meaning the company kept $0.09 of every dollar of revenue as profit.

Based on available data, ANI Pharmaceuticals, Inc. has been profitable since at least 2013. Net income reached a peak of $78.3M in FY2025. Data available for 15 fiscal years.

ANI Pharmaceuticals, Inc.'s net profit margin was 8.9% for FY2025, based on the latest annual results.

Investors sometimes search for "ANI Pharmaceuticals, Inc. net worth" — the company's market capitalization is a separate figure from ANIP net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

ANIP net income · 5 questions

ANI Pharmaceuticals, Inc. is profitable. The company reported net income of $78.3M for FY2025, a net profit margin of 8.9%. Net income was up 522.9% year-over-year. Based on available data, ANI Pharmaceuticals, Inc. has been profitable since at least 2013.

is ANIP profitabledoes ANIP make a profitANIP profitabilityANIP profitable company

▸ Source: FMP /income-statement · GAAP · ANI Pharmaceuticals, Inc. · ANI Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026